Workflow
青海春天药用资源科技股份有限公司 2025年第三季度报告

Core Viewpoint - The company, Qinghai Spring Medicine Resources Technology Co., Ltd., has announced the continuation of its accounting firm for the 2025 fiscal year and the cancellation of its supervisory board, with the audit committee taking over its responsibilities [9][71]. Financial Data - The company reported a total operating income of 212.53 million yuan and a net profit attributable to shareholders of -28.32 million yuan for the first three quarters of 2025 [45][46]. - The company has experienced continuous losses, with a net profit after deducting non-recurring gains and losses of -58.90 million yuan [45][46]. Shareholder Information - The company plans to hold its second extraordinary general meeting of 2025 on November 5, 2025, to discuss various proposals, including the appointment of the accounting firm and the cancellation of the supervisory board [58][59]. Audit Firm Appointment - The company has proposed to reappoint Zhengdan Zhiyuan (Shenzhen) Accounting Firm for the 2025 financial audit and internal control audit, with fees set at 800,000 yuan for the financial audit and 300,000 yuan for the internal control audit, totaling 1.1 million yuan, which is the same as the previous year [9][16][28]. Corporate Governance Changes - The company has decided to abolish its supervisory board, transferring its responsibilities to the audit committee, in line with updated regulations and to enhance corporate governance [71][72].